Study: Economic Burden Associated with Extended-Release vs. Immediate-Release Drug Formulations
1 Mar, 2020 | 19:43h | UTCCommentary: Extended-release drugs could be costing U.S. healthcare system billions – Reuters (free)
Commentary: Extended-release drugs could be costing U.S. healthcare system billions – Reuters (free)